Evidence map›Paper›PMID 27307648›Full record

ArticleBioinformatics (Oxford, England)2016

Analysis of aggregated cell-cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells.

A Grant Schissler, Qike Li, James L Chen, Colleen Kenost, Ikbel Achour, D Dean Billheimer, Haiquan Li, Walter W Piegorsch, Yves A Lussier

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Biologically Relevant Heterogeneity: Metrics and Practical Insights.SLAS discovery : advancing life sciences R & D · 2017
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

A Grant SchisslerCenter for Biomedical Informatics and Biostatistics (CB2) Graduate Interdisciplinary Program in Statistics Department of Medicine BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA.
Qike LiCenter for Biomedical Informatics and Biostatistics (CB2) Graduate Interdisciplinary Program in Statistics Department of Medicine BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA.
James L ChenDivision of Bioinformatics, Departments of Biomedical Informatics Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.
Colleen KenostCenter for Biomedical Informatics and Biostatistics (CB2) Department of Medicine BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA.
Ikbel AchourCenter for Biomedical Informatics and Biostatistics (CB2) Department of Medicine BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA.
D Dean BillheimerCenter for Biomedical Informatics and Biostatistics (CB2) Graduate Interdisciplinary Program in Statistics BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA.
Haiquan LiCenter for Biomedical Informatics and Biostatistics (CB2) Department of Medicine BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA.
Walter W PiegorschGraduate Interdisciplinary Program in Statistics BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA.
Yves A LussierCenter for Biomedical Informatics and Biostatistics (CB2) Graduate Interdisciplinary Program in Statistics Department of Medicine BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA The University of Arizona Cancer Center, Tucson, AZ 85719, USA Institute for Genomics and Systems Biology, The University of Chicago, Chicago, IL, 60637, USA.

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
Semantic Approaches to Phenotypic Databases AnalysesK22LM008308 · NLM · UNIVERSITY OF CHICAGO · PI LUSSIER, YVES A · 2004 to 2006
$468k
NCI NIH HHS P30 CA023074NLM NIH HHS K22 LM008308
6 · The paper itself

Abstract

motivationAs 'omics' biotechnologies accelerate the capability to contrast a myriad of molecular measurements from a single cell, they also exacerbate current analytical limitations for detecting meaningful single-cell dysregulations. Moreover, mRNA expression alone lacks functional interpretation, limiting opportunities for translation of single-cell transcriptomic insights to precision medicine. Lastly, most single-cell RNA-sequencing analytic approaches are not designed to investigate small populations of cells such as circulating tumor cells shed from solid tumors and isolated from patient blood samples.

resultsIn response to these characteristics and limitations in current single-cell RNA-sequencing methodology, we introduce an analytic framework that models transcriptome dynamics through the analysis of aggregated cell-cell statistical distances within biomolecular pathways. Cell-cell statistical distances are calculated from pathway mRNA fold changes between two cells. Within an elaborate case study of circulating tumor cells derived from prostate cancer patients, we develop analytic methods of aggregated distances to identify five differentially expressed pathways associated to therapeutic resistance. Our aggregation analyses perform comparably with Gene Set Enrichment Analysis and better than differentially expressed genes followed by gene set enrichment. However, these methods were not designed to inform on differential pathway expression for a single cell. As such, our framework culminates with the novel aggregation method, cell-centric statistics (CCS). CCS quantifies the effect size and significance of differentially expressed pathways for a single cell of interest. Improved rose plots of differentially expressed pathways in each cell highlight the utility of CCS for therapeutic decision-making. AVAILABILITY AND IMPLEMENTATION: http://www.lussierlab.org/publications/CCS/ CONTACT: yves@email.arizona.edu or piegorsch@math.arizona.edu SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Drug Resistance, NeoplasmSequence Analysis, RNATranscriptomeGene Expression ProfilingHumansMaleNeoplastic Cells, CirculatingProstatic NeoplasmsRNARNA

Identifiers

PMID27307648
PMCPMC4908332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.